Health3h agoHindustan Times

India gets its first dengue vaccine: Doctors explain who can take it, how it works and whether it's right for you

in5points

India approved QDENGA, developed by Takeda, as its first dengue vaccine for ages 4 to 60.
QDENGA protects against all four dengue virus serotypes and is administered in two doses three months apart.
Clinical studies show QDENGA reduces risk of severe disease and hospitalization but does not guarantee 100% protection.
Mosquito precautions remain essential even after vaccination, doctors emphasize.
People should consult a healthcare provider to determine if QDENGA is appropriate for them.

Story angle

Center-left

Mostly straight facts, with a light progressive or opposition-friendly tilt.

About how the story is framed, not whether the facts are true.

Center-left

Mixed factuality

Who owns this?

HT Media

Shobhana Bhartia (Birla family)

UPSC / SSC structured brief for this story — not the five-point card.

Outlet lean

3 sources

Left

Center

Right

Compare headlines

Same story, different framing

LeftHindustan Times
India approves its first dengue vaccine Qdenga: How it works, who is eligible, and why it isn't a silver bullet
The article presents Qdenga's approval factually while tempering expectations by explaining its limitations.
CenterTimes of India
India approves its first dengue vaccine QDENGA after DCGI clearance
The Times of India presents the approval as a straightforward public health milestone, with neutral factual reporting.
RightAsianet Newsable
Takeda's dengue vaccine QDENGA gets DCGI approval for use in India
The outlet frames this as a positive milestone for dengue prevention in India, highlighting the approval of a new vaccine without pre-testing requirements.

›

4 outlets